Efficacy and safety of nivolumab monotherapy in metastatic urothelial cancer (mUC): Results from the phase I/II CheckMate 032 study.
Sharma P, Bono P, Kim J, Spiliopoulou P, Calvo E, Pillai R, Ott P, De Braud F, Morse M, Le D, Jaeger D, Chan E, Harbison C, Lin C, Tschaika M, Azrilevich A, Rosenberg J. Efficacy and safety of nivolumab monotherapy in metastatic urothelial cancer (mUC): Results from the phase I/II CheckMate 032 study. Journal Of Clinical Oncology 2016, 34: 4501-4501. DOI: 10.1200/jco.2016.34.15_suppl.4501.Peer-Reviewed Original Research